Janney Montgomery Scott’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.7M Sell
283,918
-159,575
-36% -$7.44M 0.03% 462
2025
Q4
$21.5M Buy
443,493
+51,049
+13% +$2.53M 0.05% 351
2025
Q3
$18.5M Buy
392,444
+42,743
+12% +$2.06M 0.04% 383
2025
Q2
$16.9M Buy
349,701
+10,264
+3% +$524K 0.04% 389
2025
Q1
$18.8M Buy
339,437
+11,806
+4% +$639K 0.05% 348
2024
Q4
$15.8M Buy
327,631
+18,279
+6% +$929K 0.04% 409
2024
Q3
$17.8M Sell
309,352
-1,007
-0.3% -$54.4K 0.05% 372
2024
Q2
$15.1M Buy
310,359
+2,732
+0.9% +$132K 0.05% 390
2024
Q1
$15M Buy
307,627
+29,082
+10% +$1.42M 0.04% 407
2023
Q4
$13.9M Buy
278,545
+141,889
+104% +$6.94M 0.04% 402
2023
Q3
$7.33M Buy
136,656
+3,903
+3% +$208K 0.03% 536
2023
Q2
$7.16M Buy
132,753
+2,720
+2% +$146K 0.03% 576
2023
Q1
$7.08M Buy
130,033
+8,726
+7% +$424K 0.03% 522
2022
Q4
$5.88M Sell
121,307
-22,522
-16% -$989K 0.02% 615
2022
Q3
$5.47M Sell
143,829
-13,838
-9% -$617K 0.02% 585
2022
Q2
$8.07M Buy
157,667
+6,391
+4% +$339K 0.04% 432
2022
Q1
$7.77M Buy
151,276
+2,724
+2% +$141K 0.03% 455
2021
Q4
$7.44M Sell
148,552
-5,024
-3% -$248K 0.03% 495
2021
Q3
$7.4M Buy
153,576
+9,839
+7% +$500K 0.03% 471
2021
Q2
$7.57M Buy
143,737
+12,349
+9% +$644K 0.03% 450
2021
Q1
$6.5M Sell
131,388
-13,716
-9% -$659K 0.03% 461
2020
Q4
$7.05M Buy
145,104
+3,365
+2% +$166K 0.03% 428
2020
Q3
$7.11M Buy
141,739
+3,537
+3% +$182K 0.04% 375
2020
Q2
$7.05M Sell
138,202
-15,736
-10% -$765K 0.04% 357
2020
Q1
$6.73M Buy
153,938
+42,833
+39% +$2.05M 0.05% 316
2019
Q4
$5.58M Buy
111,105
+35,910
+48% +$1.68M 0.04% 428
2019
Q3
$3.48M Buy
75,195
+4,877
+7% +$210K 0.03% 555
2019
Q2
$3.04M Sell
70,318
-2,326
-3% -$98.9K 0.02% 580
2019
Q1
$3.22M Buy
72,644
+1,122
+2% +$48.1K 0.03% 536
2018
Q4
$3.1M Sell
71,522
-2,472
-3% -$109K 0.03% 497
2018
Q3
$3.31M Sell
73,994
-12,518
-14% -$535K 0.03% 523
2018
Q2
$3.46M Sell
86,512
-4,211
-5% -$166K 0.03% 483
2018
Q1
$3.64M Sell
90,723
-29
-0% -$1.21K 0.04% 458
2017
Q4
$3.9M Sell
90,752
-20,287
-18% -$935K 0.04% 427
2017
Q3
$5.53M Sell
111,039
-3,349
-3% -$162K 0.06% 312
2017
Q2
$5.48M Buy
114,388
+7,051
+7% +$337K 0.07% 299
2017
Q1
$4.86M Sell
107,337
-918
-0.8% -$38.9K 0.06% 303
2016
Q4
$4.38M Buy
108,255
+7,042
+7% +$277K 0.07% 300
2016
Q3
$3.87M Buy
+101,213
New +$4.06M 0.07% 283
2016
Q1
Sell
-60,703
Closed -$2.59M 1400
2015
Q4
$2.59M Sell
60,703
-43,800
-42% -$2.02M 0.07% 286
2015
Q3
$4.96M Sell
104,503
-4,302
-4% -$219K 0.14% 175
2015
Q2
$5.39M Buy
108,805
+11,883
+12% +$602K 0.11% 228
2015
Q1
$4.79M Buy
96,922
+11,279
+13% +$539K 0.09% 278
2014
Q4
$3.91M Buy
85,643
+45,022
+111% +$2.18M 0.08% 310
2014
Q3
$2.29M Buy
40,621
+4,581
+13% +$246K 0.05% 477
2014
Q2
$1.92M Buy
36,040
+9,609
+36% +$510K 0.04% 530
2014
Q1
$1.38M Buy
26,431
+2,616
+11% +$132K 0.03% 613
2013
Q4
$1.28M Buy
23,815
+1,396
+6% +$72K 0.03% 614
2013
Q3
$1.14M Buy
22,419
+13,862
+162% +$705K 0.03% 603
2013
Q2
$441K Buy
+8,557
New +$456K 0.05% 427

Other funds holding SNY

Janney Montgomery Scott's SNY Position: Q1 2026 in Review

Janney Montgomery Scott reduced its Sanofi (SNY) stake by 36% in Q1 2026, selling an estimated $7.44M and leaving 283,918 shares worth $13.7M. The position accounts for 0.03% of the portfolio, ranked #462.

Janney Montgomery Scott first reported a position in SNY in Q2 2013 and has held it in 50 quarters since. The position peaked at $21.5M in Q4 2025. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Janney Montgomery Scott held 283,918 shares of Sanofi worth $13.7M as of Q1 2026.
  • Janney Montgomery Scott sold 159,575 Sanofi shares in Q1 2026, an estimated $7.44M.
  • Sanofi made up 0.03% of Janney Montgomery Scott's portfolio in Q1 2026, its #462 holding.
  • Janney Montgomery Scott first reported a position in Sanofi in Q2 2013 and has held it in 50 quarters since.
  • Janney Montgomery Scott's Sanofi position peaked at $21.5M in Q4 2025.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Janney Montgomery Scott's 13F filing for Q1 2026, filed 22 Apr 2026.